OCEA.OOTC
- Ocean Biomediacal Inc
報價延遲最少15分鐘:2025/07/29 16:47 EDT
盤後時段
|
||||
|
-- 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.0067
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.91/-0.68
|
|
企業價值
1.51M
|
| 資產負債 |
|
每股賬面淨值
-0.40
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||
|
||||||||||||||||
報價延遲最少15分鐘：2025/07/29 16:47 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. |
